Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 2/20 | 0.42 |
| ▸ | ACACB | O00763 | 1/20 | 0.40 |
| ▸ | ACACA | Q13085 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.36 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | RAD52 | P43351 | 1/20 | 0.36 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7706121 | 0.86 | GPR84 (0.43) | GPR84FFAR4FFAR1NFKB1FAAH | |
| SCHEMBL5188208 | 0.83 | LMNA (0.38) | FAAHMAPTLMNA | |
| SCHEMBL5188738 | 0.83 | LMNA (0.38) | FAAHMAPTLMNA | |
| SCHEMBL5186531 | 0.82 | LMNA (0.41) | FAAHMAPTLMNAMEN1KMT2A | |
| SCHEMBL23837218 | 0.78 | FFAR4 (0.54) | GPR84FFAR4FFAR1NFKB1FAAH | |
| SCHEMBL17878534 | 0.77 | CA1 (0.38) | NFKB1LMNA | |
| SCHEMBL5188239 | 0.77 | CTSK (0.31) | LMNA | |
| SCHEMBL7882764 | 0.76 | FFAR4 (0.59) | GPR84FFAR4FFAR1NFKB1FAAH | |
| SCHEMBL27177156 | 0.75 | LMNA (0.47) | MAPTLMNAACE2KDM4EDUSP3 | |
| SCHEMBL27176380 | 0.75 | LMNA (0.47) | MAPTLMNAACE2KDM4EDUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6369248-B1 | HYDROXY ESTERS FOR PERFUMES | GIVAUDAN SA (CH) | 2002-04-09 | — | — | US | claimed |
| EP-0989970-A1 | FRAGRANCE PRECURSOR COMPOUNDS | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 2000-04-05 | — | — | EP | claimed |
| WO-1998058899-A1 | FRAGRANCE PRECURSOR COMPOUNDS | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1998-12-30 | — | — | WO | claimed |
| EP-1760067-A2 | Compounds with protected hydroxy groups | Givaudan SA (CH) | 2007-03-07 | — | — | EP | disclosed |
| EP-0952142-B1 | Compounds with protected hydroxy groups | GIVAUDAN SA (CH) | 2006-10-18 | — | — | EP | disclosed |
| US-6627763-B2 | As precursors for organoleptic agents, such as fragrances, and masking agents and for antimicrobial agents | GIVAUDAN SA | 2003-09-30 | — | — | US | disclosed |
| US-20020193269-A1 | Compounds having protected hydroxy groups | GIVAUDAN SA, A SWITZERLAND CORPORATION | 2002-12-19 | — | — | US | disclosed |
| US-6479682-B1 | Compounds having protected hydroxy groups | GIVAUDAN SA (CH) | 2002-11-12 | — | — | US | disclosed |
| US-6437150-B1 | WHEN ACTIVATED, THE ESTERS, CARBONATES, OR CARBAMATES ARE CLEAVED TO FORM ONE OR MORE LACTONES AND ORGANOLEPTICS SUCH AS FRAGRANCES, OR MASKING AGENTS, OR ANTIMICROBIAL AGENTS; STABLE UNDER TRANSPORT AND STORAGE CONDITIONS | GIVAUDAN SA (CH) | 2002-08-20 | — | — | US | disclosed |
| US-6369248-B1 | HYDROXY ESTERS FOR PERFUMES | GIVAUDAN SA (CH) | 2002-04-09 | — | — | US | disclosed |
| EP-0989970-A1 | FRAGRANCE PRECURSOR COMPOUNDS | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 2000-04-05 | — | — | EP | disclosed |
| EP-0952142-A1 | Compounds with protected hydroxy groups | Givaudan Roure (International) S.A. (CH) | 1999-10-27 | — | — | EP | disclosed |
| WO-1998058899-A1 | FRAGRANCE PRECURSOR COMPOUNDS | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1998-12-30 | — | — | WO | disclosed |